Older drugs with limited trial evidence

Are they worth the expense? The case of repository corticotropin marketed as H.P. Acthar Gel

Research output: Contribution to journalComment/debate

Original languageEnglish (US)
Pages (from-to)791-793
Number of pages3
JournalAnnals of internal medicine
Volume170
Issue number11
DOIs
StatePublished - Jan 1 2019

Fingerprint

Adrenocorticotropic Hormone
Gels
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Internal Medicine

Cite this

@article{f652e782bb6246ac90abd3be052b34cf,
title = "Older drugs with limited trial evidence: Are they worth the expense? The case of repository corticotropin marketed as H.P. Acthar Gel",
author = "Ali Duarte-Garc{\'i}a and Matteson, {Eric Lawrence} and Shah, {Nilay D}",
year = "2019",
month = "1",
day = "1",
doi = "10.7326/M18-3513",
language = "English (US)",
volume = "170",
pages = "791--793",
journal = "Annals of Internal Medicine",
issn = "0003-4819",
publisher = "American College of Physicians",
number = "11",

}

TY - JOUR

T1 - Older drugs with limited trial evidence

T2 - Are they worth the expense? The case of repository corticotropin marketed as H.P. Acthar Gel

AU - Duarte-García, Ali

AU - Matteson, Eric Lawrence

AU - Shah, Nilay D

PY - 2019/1/1

Y1 - 2019/1/1

UR - http://www.scopus.com/inward/record.url?scp=85067125429&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85067125429&partnerID=8YFLogxK

U2 - 10.7326/M18-3513

DO - 10.7326/M18-3513

M3 - Comment/debate

VL - 170

SP - 791

EP - 793

JO - Annals of Internal Medicine

JF - Annals of Internal Medicine

SN - 0003-4819

IS - 11

ER -